Jonghyeon Kim
About
In The Last Decade
Jonghyeon Kim
24 papers receiving 1.3k citations
Hit Papers
Peers
Comparison fields: 5 of 116
- Ophthalmology 666
- Radiology, Nuclear Medicine and Imaging 310
- Rheumatology 224
- Molecular Biology 208
- Pharmacology 206
Countries citing papers authored by Jonghyeon Kim
This map shows the geographic impact of Jonghyeon Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonghyeon Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonghyeon Kim more than expected).
Fields of papers citing papers by Jonghyeon Kim
This network shows the impact of papers produced by Jonghyeon Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonghyeon Kim. The network helps show where Jonghyeon Kim may publish in the future.
Co-authorship network of co-authors of Jonghyeon Kim
This figure shows the co-authorship network connecting the top 25 collaborators of Jonghyeon Kim. A scholar is included among the top collaborators of Jonghyeon Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonghyeon Kim. Jonghyeon Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Efficacy and safety of selective TYK2 inhibitor, deucravacitinib, in a phase II trial in psoriatic arthritis breakdown → | 134 |
| 2 | 1 | |
| 3 | 16 | |
| 4 | 3 | |
| 5 | 15 | |
| 6 | 14 | |
| 7 | 8 | |
| 8 | 24 | |
| 9 | 27 | |
| 10 | 269 | |
| 11 | 51 | |
| 12 | 0 | |
| 13 | 78 | |
| 14 | 208 | |
| 15 | 101 | |
| 16 | 16 | |
| 17 | 1 | |
| 18 | 47 | |
| 19 | 17 | |
| 20 | 18 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.